Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study
<i>Background:</i> Accelerating recovery and preventing the progression to more severe outcomes for patients with coronavirus disease 2019 (COVID-19) is of paramount importance. Non-steroidal anti-inflammatory agents (NSAIDs) have been widely adopted in the international recommendations...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/13/3/65 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849704945346936832 |
|---|---|
| author | Domenica Francesca Mariniello Raffaella Pagliaro Vito D’Agnano Angela Schiattarella Fabio Perrotta Andrea Bianco |
| author_facet | Domenica Francesca Mariniello Raffaella Pagliaro Vito D’Agnano Angela Schiattarella Fabio Perrotta Andrea Bianco |
| author_sort | Domenica Francesca Mariniello |
| collection | DOAJ |
| description | <i>Background:</i> Accelerating recovery and preventing the progression to more severe outcomes for patients with coronavirus disease 2019 (COVID-19) is of paramount importance. Non-steroidal anti-inflammatory agents (NSAIDs) have been widely adopted in the international recommendations for non-severe COVID-19 management. Among NSAIDs, evidence about the efficacy of ketoprofen lysin salt (KLS) in the treatment of non-severe COVID-19 has not been reported. <i>Methods:</i> This retrospective study compared the outcomes of 120 patients with mild to moderate COVID-19 treated at home with KLS between March 2021 and May 2023 compared with the outcomes of 165 patients who received corticosteroids. The outcomes included hospitalization, the need for oxygen supplementation, clinical recovery from acute COVID-19, and time to negative swabs. <i>Results:</i> Symptoms persisted in a lower percentage of patients in the KLS group compared to the corticosteroids group (<i>p</i> < 0.0001) and for a shorter period (<i>p</i> = 0.046). We found 6 patients (5%) in the KLS group were hospitalized compared to 45 (27%) in the corticosteroids group (<i>p</i> < 0.001). A higher percentage of patients in the corticosteroids group require oxygen administration (<i>p</i> < 0.001). In addition, patients taking corticosteroids showed a longer viral shedding period compared to those taking KLS (<i>p</i> = 0.004). A final multivariate analysis suggests that KLS might reduce hospitalization risk, the need for oxygen supplementation, and the persistence of post-COVID-19 symptoms when compared to an oral corticosteroid after adjusting for significant co-variables. <i>Conclusions:</i> KLS might have a positive effect on clinical recovery in non-severe COVID-19 patients. A comparison with other NSAIDs in terms of difference in efficacy and safety should be investigated in further trials. |
| format | Article |
| id | doaj-art-bbc2620f2a78417b97b74831d214577a |
| institution | DOAJ |
| issn | 2226-4787 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacy |
| spelling | doaj-art-bbc2620f2a78417b97b74831d214577a2025-08-20T03:16:35ZengMDPI AGPharmacy2226-47872025-05-011336510.3390/pharmacy13030065Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective StudyDomenica Francesca Mariniello0Raffaella Pagliaro1Vito D’Agnano2Angela Schiattarella3Fabio Perrotta4Andrea Bianco5Department of Translational Medical Sciences, University of Campania ‘L. Vanvitelli’, 80131 Naples, ItalyDepartment of Translational Medical Sciences, University of Campania ‘L. Vanvitelli’, 80131 Naples, ItalyDepartment of Translational Medical Sciences, University of Campania ‘L. Vanvitelli’, 80131 Naples, ItalyDepartment of Translational Medical Sciences, University of Campania ‘L. Vanvitelli’, 80131 Naples, ItalyDepartment of Translational Medical Sciences, University of Campania ‘L. Vanvitelli’, 80131 Naples, ItalyDepartment of Translational Medical Sciences, University of Campania ‘L. Vanvitelli’, 80131 Naples, Italy<i>Background:</i> Accelerating recovery and preventing the progression to more severe outcomes for patients with coronavirus disease 2019 (COVID-19) is of paramount importance. Non-steroidal anti-inflammatory agents (NSAIDs) have been widely adopted in the international recommendations for non-severe COVID-19 management. Among NSAIDs, evidence about the efficacy of ketoprofen lysin salt (KLS) in the treatment of non-severe COVID-19 has not been reported. <i>Methods:</i> This retrospective study compared the outcomes of 120 patients with mild to moderate COVID-19 treated at home with KLS between March 2021 and May 2023 compared with the outcomes of 165 patients who received corticosteroids. The outcomes included hospitalization, the need for oxygen supplementation, clinical recovery from acute COVID-19, and time to negative swabs. <i>Results:</i> Symptoms persisted in a lower percentage of patients in the KLS group compared to the corticosteroids group (<i>p</i> < 0.0001) and for a shorter period (<i>p</i> = 0.046). We found 6 patients (5%) in the KLS group were hospitalized compared to 45 (27%) in the corticosteroids group (<i>p</i> < 0.001). A higher percentage of patients in the corticosteroids group require oxygen administration (<i>p</i> < 0.001). In addition, patients taking corticosteroids showed a longer viral shedding period compared to those taking KLS (<i>p</i> = 0.004). A final multivariate analysis suggests that KLS might reduce hospitalization risk, the need for oxygen supplementation, and the persistence of post-COVID-19 symptoms when compared to an oral corticosteroid after adjusting for significant co-variables. <i>Conclusions:</i> KLS might have a positive effect on clinical recovery in non-severe COVID-19 patients. A comparison with other NSAIDs in terms of difference in efficacy and safety should be investigated in further trials.https://www.mdpi.com/2226-4787/13/3/65ketoprofen lysine saltNSAIDsCOVID-19SARS-CoV-2 |
| spellingShingle | Domenica Francesca Mariniello Raffaella Pagliaro Vito D’Agnano Angela Schiattarella Fabio Perrotta Andrea Bianco Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study Pharmacy ketoprofen lysine salt NSAIDs COVID-19 SARS-CoV-2 |
| title | Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study |
| title_full | Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study |
| title_fullStr | Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study |
| title_full_unstemmed | Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study |
| title_short | Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study |
| title_sort | ketoprofen lysine salt versus corticosteroids in early outpatient management of mild and moderate covid 19 a retrospective study |
| topic | ketoprofen lysine salt NSAIDs COVID-19 SARS-CoV-2 |
| url | https://www.mdpi.com/2226-4787/13/3/65 |
| work_keys_str_mv | AT domenicafrancescamariniello ketoprofenlysinesaltversuscorticosteroidsinearlyoutpatientmanagementofmildandmoderatecovid19aretrospectivestudy AT raffaellapagliaro ketoprofenlysinesaltversuscorticosteroidsinearlyoutpatientmanagementofmildandmoderatecovid19aretrospectivestudy AT vitodagnano ketoprofenlysinesaltversuscorticosteroidsinearlyoutpatientmanagementofmildandmoderatecovid19aretrospectivestudy AT angelaschiattarella ketoprofenlysinesaltversuscorticosteroidsinearlyoutpatientmanagementofmildandmoderatecovid19aretrospectivestudy AT fabioperrotta ketoprofenlysinesaltversuscorticosteroidsinearlyoutpatientmanagementofmildandmoderatecovid19aretrospectivestudy AT andreabianco ketoprofenlysinesaltversuscorticosteroidsinearlyoutpatientmanagementofmildandmoderatecovid19aretrospectivestudy |